vision changes tirzepatide Popular GLP-1 medications used to treat type 2 diabetes and obesity—semaglutide (Ozempic and Wegovy) and (Mounjaro and Zepbound)—may be linked to a small increase in the risk of a rare eye Comparative ocular outcomes of tirzepatide

Improved Bone Density

And we offer real flexibility on how you fund it: - Traditional cost share - Defined contribution offerings - Manufacturer-direct cash pay Were also proud to be the only solution with published 4-year outcomes using GLPs across every workforce type: office, shift, field, and more

PlexusDx explains how these medications work together and what you need to know before starting treatment

Zooming out, the obesity market is now clearly split across modalities: Novo Nordisk still anchors the peptide side with semaglutide, while oral small molecules are accelerating (orforglipron, elecoglipron and Roches Carmot deal)

A GLP-1 receptor agonist studied in metabolic research

However, the role of endogenous GLP-1 in the attenuation of reward-oriented behavior, and the essential domains of the mesolimbic system mediating these beneficial effects, are largely unknown